M Pharmaceutical in-licenses undisclosed compound

M Pharmaceutical Inc. (CNSX:MQ; OTCQB:MPHMF) received rights to an undisclosed drug from an undisclosed company. M Pharmaceutical, which develops technologies for weight management and female health, said it believes the product qualifies for orphan drug and rare pediatric disease status in the U.S. The company declined to disclose details...